These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8813133

  • 1. Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction.
    Bai R, Schwartz RE, Kepler JA, Pettit GR, Hamel E.
    Cancer Res; 1996 Oct 01; 56(19):4398-406. PubMed ID: 8813133
    [Abstract] [Full Text] [Related]

  • 2. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
    Bai R, Durso NA, Sackett DL, Hamel E.
    Biochemistry; 1999 Oct 26; 38(43):14302-10. PubMed ID: 10572005
    [Abstract] [Full Text] [Related]

  • 3. Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions.
    Bai R, Taylor GF, Schmidt JM, Williams MD, Kepler JA, Pettit GR, Hamel E.
    Mol Pharmacol; 1995 May 26; 47(5):965-76. PubMed ID: 7746283
    [Abstract] [Full Text] [Related]

  • 4. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A, Sept D.
    Biochemistry; 2004 Nov 09; 43(44):13955-62. PubMed ID: 15518544
    [Abstract] [Full Text] [Related]

  • 5. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R, Cichacz ZA, Herald CL, Pettit GR, Hamel E.
    Mol Pharmacol; 1993 Oct 09; 44(4):757-66. PubMed ID: 8232226
    [Abstract] [Full Text] [Related]

  • 6. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.
    Bai R, Taylor GF, Cichacz ZA, Herald CL, Kepler JA, Pettit GR, Hamel E.
    Biochemistry; 1995 Aug 01; 34(30):9714-21. PubMed ID: 7626642
    [Abstract] [Full Text] [Related]

  • 7. Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography.
    Cruz-Monserrate Z, Mullaney JT, Harran PG, Pettit GR, Hamel E.
    Eur J Biochem; 2003 Sep 01; 270(18):3822-8. PubMed ID: 12950266
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
    Bai R, Pettit GR, Hamel E.
    Biochem Pharmacol; 1990 Jun 15; 39(12):1941-9. PubMed ID: 2353935
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stability of drug-induced tubulin rings by fluorescence correlation spectroscopy.
    Boukari H, Nossal R, Sackett DL.
    Biochemistry; 2003 Feb 11; 42(5):1292-300. PubMed ID: 12564932
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of action cryptophycin. Interaction with the Vinca alkaloid domain of tubulin.
    Smith CD, Zhang X.
    J Biol Chem; 1996 Mar 15; 271(11):6192-8. PubMed ID: 8626409
    [Abstract] [Full Text] [Related]

  • 14. Interaction of cryptophycin 1 with tubulin and microtubules.
    Kerksiek K, Mejillano MR, Schwartz RE, Georg GI, Himes RH.
    FEBS Lett; 1995 Dec 11; 377(1):59-61. PubMed ID: 8543019
    [Abstract] [Full Text] [Related]

  • 15. Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers.
    Hamel E, Lin CM, Flynn E, D'Amato RJ.
    Biochemistry; 1996 Jan 30; 35(4):1304-10. PubMed ID: 8573587
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D, Himes RH, Moore RE, Wilson L, Jordan MA.
    Biochemistry; 1997 Oct 21; 36(42):12948-53. PubMed ID: 9335554
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activity.
    Verdier-Pinard P, Kepler JA, Pettit GR, Hamel E.
    Mol Pharmacol; 2000 Jan 21; 57(1):180-7. PubMed ID: 10617693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.